SGHT Q2 2022 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+37.4% YoY

Gross Profit

$14M84.1% margin

Operating Income

-$23M-132.7% margin

Net Income

-$24M-138.4% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

+15.8%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$241M

Total Liabilities

$49M

Stockholders' Equity

$192M

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$13M	+37.4%
Gross Profit	$14M	$10M	+41.7%
Operating Income	-$23M	-$11M	-106.4%
Net Income	-$24M	-$18M	-35.4%

Revenue Segments

Surgical Glaucoma

$16M92%

Dry Eye

$1M8%